The Asian Fund for Cancer Research congratulates our five semi-finalists of the 2022 BRACE Award Venture Competition. The BRACE Award aims to provide vital support to early-stage biotechs, enabling them to accelerate their innovative therapeutics, diagnostics and cancer prevention products into the clinic, with the ultimate goal of improving outcomes for patients affected by cancer globally.
The winner of the 2022 BRACE Award Venture Competition will receive up to US$600,000 from AFCR and co-investors, which will allow the startup to pursue proof of concept and proof of value on the path to clinical trials and, eventually, to new effective cancer technologies that could save patients’ lives.
In addition, the BRACE Award is looking to name one of our semi-finalists as the “Best Public Communicator”. Who will it be? We can’t all be on the official Judging Committee… but we can ALL Cast our Vote!
Ready to do more? DONATE NOW to help more patients in Asia and Worldwide.
Bee Hui Liu, Ph.D.
Zhi-Ren Liu, Ph.D.
CEO & Founder
Rajiv Datar, Ph.D.
CEO & Co-Founder
Peh Yean Cheah, Ph.D.
Founder & CEO
Vote submission e-mail addresses will be added to the Asian Fund for Cancer Research’s general communication recipient list. These e-mail addresses will NEVER be sold, rented or otherwise conveyed to any other organization except only the National Foundation for Cancer Research and AIM-HI Accelerator Fund, both of which are BRACE Award Venture Competition sponsors—and they themselves will NEVER sell, rent or otherwise convey the e-mail addresses to any other organization, without exception.